Page last updated: 2024-08-24

plerixafor and Breast Cancer

plerixafor has been researched along with Breast Cancer in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's20 (86.96)24.3611
2020's3 (13.04)2.80

Authors

AuthorsStudies
Bai, R; Liang, Z; Shim, H; Wu, R; Xie, Y; Yao, C; Yoon, Y; Yu, W1
Arteaga, CL; Chu, F; Gagea, M; Hanash, S; Hanker, AB; Liu, S; Liu, W; Marchese, A; Neelapu, SS; Nguyen, N; Singareeka Raghavendra, A; Tripathy, D; Xie, SM; Yang-Kolodji, G; Zimmermann, J1
He, J; Kong, J; Lin, B; Liu, T; Lu, Y; Luo, Y; Ma, H; Pang, J; Qin, K; Tian, H; Yang, X; Yuan, W1
Jiang, J; Li, G; Sakurai, K; Shen, N; Song, W; Tang, Z; Yu, H1
Gong, S; Li, H; Oupicky, D; Sun, M; Wu, J; Zhang, F1
Li, C; Li, H; Oupicky, D; Qiao, H; Sun, M; Wang, K; Yang, X; Zhou, Z1
Chan, WC; Hao, Y; Ng, TB; Pan, WL; Wan, DC; Wang, Y; Wong, JH1
Barbul, A; Busch, JI; Cervoni-Curet, FN; Kavalukas, SL; Niederhuber, JE; Stuelten, CH; Sutton, E; Wakefield, LM; Webster, JD1
Ablett, MP; Clarke, RB; Farnie, G; O'Brien, CS; Sims, AH1
Cavnar, SP; Chang, SL; Linderman, JJ; Luker, GD; Luker, KE; Moudgil, P; Ray, P; Takayama, S1
Hans, F; Hattermann, K; Held-Feindt, J; Holzenburg, E; Lucius, R; Mentlein, R1
Balboni, A; Cherukuri, P; DeCastro, AJ; DiRenzo, J1
Duvall-Noelle, N; Karwandyar, A; Raman, D; Richmond, A1
Bracke, M; De Wagter, C; De Wever, O; Descamps, B; Feys, L; Vanhove, C; Veldeman, L; Vermeulen, S; Vral, A1
An, F; Fang, S; Jin, D; Kong, J; Li, J; Li, X; Lin, B; Liu, L; Liu, T; Luo, Y; Yang, X; Zhang, W1
Burness, ML; Cheng, Q; Cheng, R; Comatas, K; Kim Lyerly, H; Lee, CH; Magnani, J; McCall, CM; Olivere, L; Price, TT; Sipkins, DA; Sivan, A; Warner, MJ1
Bieche, I; Kieffer, Y; Lefort, S; Marangoni, E; Mechta-Grigoriou, F; Sirven, P; Thuleau, A; Vincent-Salomon, A1
Li, H; Oupicky, D; Ping, Q; Sun, M; Wang, K; Yang, X; Zhou, Y1
Cronin, PA; Redmond, HP; Wang, JH1
Antoon, JW; Beckman, BS; Burow, ME; Elliott, S; Muir, SE; Rhodes, LV1
Bratton, MR; Burow, ME; Collins-Burow, BM; Elliott, S; Muir, SE; Nephew, KP; Rhodes, LV; Salvo, VA; Tate, CR; Tilghman, SL; Zhu, Y1
Chudakov, DM; Lewin, SA; Luker, GD; Luker, KE; Mihalko, LA; Ray, P; Schmidt, BT; Shcherbo, D1
Bouchez, LC; Cho, CY; Dubrovska, A; Hartung, A; Reddy, VA; Schultz, PG; Walker, JR1

Other Studies

23 other study(ies) available for plerixafor and Breast Cancer

ArticleYear
Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.
    European journal of medicinal chemistry, 2020, Jan-01, Volume: 185

    Topics: Amides; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Proliferation; Chemokine CXCL12; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Receptors, CXCR4; Structure-Activity Relationship; Tumor Cells, Cultured; Wound Healing

2020
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
    Breast cancer research : BCR, 2023, 06-06, Volume: 25, Issue:1

    Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Humans; Leukocytes, Mononuclear; Mice; Mitosis; Receptor, ErbB-2; Receptors, CXCR4; Trastuzumab; Tumor Microenvironment

2023
A Novel Tissue-Based Liver-Kidney-on-a-Chip Can Mimic Liver Tropism of Extracellular Vesicles Derived from Breast Cancer Cells.
    Biotechnology journal, 2020, Volume: 15, Issue:2

    Topics: Animals; Benzylamines; Biomimetics; Breast Neoplasms; Cyclams; Extracellular Vesicles; Female; Heterocyclic Compounds; Humans; Kidney; Lab-On-A-Chip Devices; Liver; Microfluidics; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Tropism

2020
Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously.
    Biomaterials science, 2019, Dec-01, Volume: 7, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Breast Neoplasms; Cell Proliferation; Cell Survival; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Receptors, CXCR4; Stilbenes; Theranostic Nanomedicine; Up-Regulation; Xenograft Model Antitumor Assays

2019
CXCR4-Targeted and Redox Responsive Dextrin Nanogel for Metastatic Breast Cancer Therapy.
    Biomacromolecules, 2017, Jun-12, Volume: 18, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Cyclams; Dextrins; Doxorubicin; Drug Carriers; Female; Gels; Gene Expression; Heterocyclic Compounds; Humans; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanostructures; Neoplasm Proteins; Oxidation-Reduction; Protein Binding; Receptors, CXCR4; Xenograft Model Antitumor Assays

2017
Near-infrared light-triggered drug release from a multiple lipid carrier complex using an all-in-one strategy.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, 09-10, Volume: 261

    Topics: Animals; Benzylamines; Breast Neoplasms; Cyclams; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Heterocyclic Compounds; Hydrophobic and Hydrophilic Interactions; Indoles; Infrared Rays; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Nanostructures; Neoplasm Metastasis

2017
Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells.
    Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:11

    Topics: Adult; Aged; Antimicrobial Cationic Peptides; Benzylamines; Binding Sites; Breast; Breast Neoplasms; Cathelicidins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lymphatic Metastasis; Mesenchymal Stem Cells; Middle Aged; Molecular Docking Simulation; Protein Binding; Receptors, CXCR4; Signal Transduction; Tumor Microenvironment; Up-Regulation

2018
SDF-1α mediates wound-promoted tumor growth in a syngeneic orthotopic mouse model of breast cancer.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Analysis of Variance; Animals; Azo Compounds; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Collagen; Cyclams; Enzyme-Linked Immunosorbent Assay; Female; Heterocyclic Compounds; Immunohistochemistry; Mice; Mice, Inbred BALB C; Microarray Analysis; Signal Transduction; Statistics, Nonparametric; Wounds and Injuries

2013
A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity.
    Oncotarget, 2014, Feb-15, Volume: 5, Issue:3

    Topics: Anoikis; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cyclams; Female; Gene Expression; Heterocyclic Compounds; Humans; MCF-7 Cells; Neoplastic Stem Cells; Receptors, CXCR4; Signal Transduction

2014
Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis.
    Integrative biology : quantitative biosciences from nano to macro, 2014, Volume: 6, Issue:5

    Topics: Animals; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis; Cyclams; Female; Heterocyclic Compounds; Humans; Mice, Inbred C57BL; Microfluidics; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Protein Isoforms; Receptors, CXCR; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm

2014
Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
    Cell and tissue research, 2014, Volume: 357, Issue:1

    Topics: Apoptosis; Benzylamines; Breast Neoplasms; Chemokine CXCL12; Cyclams; Female; Heterocyclic Compounds; Humans; Ligands; MCF-7 Cells; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; Stimulation, Chemical

2014
ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:1

    Topics: Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemotaxis; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; MCF-7 Cells; Neoplastic Stem Cells; Promoter Regions, Genetic; Protein Isoforms; Receptors, CXCR4; Transcription Factors; Tumor Suppressor Proteins

2015
LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
    Oncogene, 2016, Mar-03, Volume: 35, Issue:9

    Topics: Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; Benzylamines; Breast Neoplasms; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Cytoskeletal Proteins; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Epigenesis, Genetic; Gene Knockdown Techniques; Heterocyclic Compounds; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; LIM Domain Proteins; Prognosis; Proteomics; Signal Transduction; Snail Family Transcription Factors; Transcription Factors; Tumor Microenvironment; Ubiquitin-Protein Ligases

2016
Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.
    Oncotarget, 2015, Sep-29, Volume: 6, Issue:29

    Topics: Animals; Benzylamines; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Cellular Senescence; Chemokine CXCL12; Culture Media, Conditioned; Cyclams; DNA Breaks, Double-Stranded; Extracellular Signal-Regulated MAP Kinases; Female; Heterocyclic Compounds; Humans; Intramolecular Oxidoreductases; Lung; Lung Diseases; Lung Neoplasms; Macrophage Migration-Inhibitory Factors; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Proto-Oncogene Proteins c-akt; Radiotherapy; Receptors, CXCR4; Recombinant Proteins; Signal Transduction; STAT3 Transcription Factor

2015
A novel microfluidic model can mimic organ-specific metastasis of circulating tumor cells.
    Oncotarget, 2016, Nov-29, Volume: 7, Issue:48

    Topics: Animals; Antineoplastic Agents; Benzylamines; Breast Neoplasms; Cell Adhesion; Cell Movement; Chemokines; Coculture Techniques; Cyclams; Female; Heterocyclic Compounds; Human Umbilical Vein Endothelial Cells; Humans; Lab-On-A-Chip Devices; Lung Neoplasms; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Microfluidic Analytical Techniques; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Organ Specificity; Primary Cell Culture; Rats, Sprague-Dawley; Salivary Gland Neoplasms; Time Factors

2016
Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone.
    Science translational medicine, 2016, 05-25, Volume: 8, Issue:340

    Topics: Animals; Benzylamines; Bone Marrow; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Cyclams; E-Selectin; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Immunohistochemistry; MCF-7 Cells; Mice; Mice, SCID; Microscopy, Confocal; Neoplasm Micrometastasis; Neoplasm Recurrence, Local; Protein Binding; Receptors, CXCR4; Tumor Cells, Cultured

2016
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.
    Oncogene, 2017, 03-02, Volume: 36, Issue:9

    Topics: Animals; Anti-HIV Agents; Apoptosis; Benzylamines; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptides; Receptor, ErbB-2; Receptors, CXCR4; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2017
Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy.
    Acta biomaterialia, 2017, 04-15, Volume: 53

    Topics: Animals; Antineoplastic Agents; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Cyclams; Delayed-Action Preparations; Female; Heterocyclic Compounds; Indoles; Lipids; Liposomes; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Nanocapsules; Particle Size; Photochemotherapy; Photosensitizing Agents; Treatment Outcome

2017
Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.
    BMC cancer, 2010, May-21, Volume: 10

    Topics: Animals; Antibodies, Monoclonal; Benzylamines; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Membrane; Chemokine CXCL12; Chemotaxis; Cyclams; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Mice; Neoplasm Invasiveness; Receptors, CXCR4; Recombinant Proteins; Time Factors; Up-Regulation

2010
Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
    Molecular cancer, 2010, Nov-18, Volume: 9

    Topics: Benzylamines; Breast Neoplasms; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Coculture Techniques; Cyclams; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Mesenchymal Stem Cells; Microscopy, Fluorescence; Receptors, CXCR4; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction

2010
Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.
    Experimental cell research, 2011, Nov-01, Volume: 317, Issue:18

    Topics: Animals; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Estrogen Receptor alpha; Female; Gene Expression Profiling; Heterocyclic Compounds; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; MicroRNAs; Polymerase Chain Reaction; Receptors, CXCR4; Signal Transduction

2011
In vivo imaging of ligand receptor binding with Gaussia luciferase complementation.
    Nature medicine, 2011, Dec-04, Volume: 18, Issue:1

    Topics: Animals; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; HEK293 Cells; Heterocyclic Compounds; Humans; Ligands; Luciferases; Luminescent Measurements; Mice; Molecular Imaging; Neoplasms, Experimental; Protein Binding; Receptors, CXCR; Receptors, CXCR4

2011
CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling.
    British journal of cancer, 2012, Jun-26, Volume: 107, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cyclams; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neoplastic Stem Cells; Receptors, Aryl Hydrocarbon; Receptors, CXCR4; Signal Transduction; Tamoxifen; Transcriptional Activation; Transplantation, Heterologous

2012